Stay updated on Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.5 to v3.6.6, indicating a newer version of the page. This update reflects an updated page revision without altering the study data.
    Difference
    0.0%
    Check dated 2026-09-01T18:10:49.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    An NIH funding line, '2018 ( U.S. NIH Grant/Contract )', was added to the funding information section, signaling NIH support for the LEAP-004 trial. This provides background on the source of funding for the study.
    Difference
    0.0%
    Check dated 2026-08-25T19:34:15.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This update reflects a page revision and does not affect the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-08-11T17:59:11.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, indicating a new build of the page.
    Difference
    0.0%
    Check dated 2026-07-28T14:41:12.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The revision label in the study documents section was updated from v3.6.0 to v3.6.3, indicating a newer version of the protocol/document referenced on the page.
    Difference
    0.0%
    Check dated 2026-06-30T01:08:42.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page gains new navigation items such as No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study, and Intervention/Treatment, along with a revision tag for v3.6.0. The older heading Intervention / Treatment and the v3.5.5 revision were removed.
    Difference
    0.4%
    Check dated 2026-06-15T14:51:12.000Z thumbnail image

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.